Top

Published in:

01-04-2017 | Review Article

Review of Cardiovascular Imaging in the Journal of Nuclear Cardiology in 2016. Part 1 of 2: Positron Emission Tomography, Computed Tomography and Magnetic Resonance

Authors: Wael AlJaroudi, MD, Fadi G. Hage, MD

Published in: Journal of Nuclear Cardiology | Issue 2/2017

Abstract

Several original articles and editorials have been published in the Journal of Nuclear Cardiology last year. It has become a tradition at the beginning of each year to summarize some of these key articles (AlJaroudi and Hage in J Nucl Cardiol 22:507-512, 2015, 23:122-130, 2016; Hage and AlJaroudi in J Nucl Cardiol 22:714-719, 2015; 23:493-498, 2016). In this part one, we will discuss some of the progress made in patients with infiltrative disease, cardiomyopathies (non-ischemic, ischemic, and diabetic), hybrid and molecular imaging, using advancement in positron emission tomography, computed tomography, and magnetic resonance imaging.

AlJaroudi WA, Hage FG. Review of cardiovascular imaging in the journal of nuclear cardiology in 2014: Part 1 of 2: Positron emission tomography, computed tomography, and neuronal imaging. J Nucl Cardiol 2015;22:507-12.CrossRefPubMed

Hage FG, AlJaroudi WA. Review of cardiovascular imaging in the journal of nuclear cardiology in 2014: Part 2 of 2: Myocardial perfusion imaging. J Nucl Cardiol 2015;22:714-9.CrossRefPubMed

AlJaroudi WA, Hage FG. Review of cardiovascular imaging in the journal of nuclear cardiology in 2015: Part 1 of 2: Plaque imaging, positron emission tomography, computed tomography, and magnetic resonance. J Nucl Cardiol 2016;23:122-30.CrossRefPubMed

Hage FG, AlJaroudi WA. Review of cardiovascular imaging in the journal of nuclear cardiology in 2015: Part 2 of 2: Myocardial perfusion imaging. J Nucl Cardiol 2016;23:493-8.CrossRefPubMed

Bravo PE, Tahari A, Pozios I, Luo HC, Bengel FM, Wahl RL, et al. Apparent left ventricular cavity dilatation during PET/CT in hypertrophic cardiomyopathy: Clinical predictors and potential mechanisms. J Nucl Cardiol 2016;23:1304-14.CrossRefPubMed

Brunken RC. Why LV dilatation with vasodilator stress in hypertrophic cardiomyopathy? J Nucl Cardiol 2016;23:1315-8.CrossRefPubMed

Manabe O, Yoshinaga K, Ohira H, Masuda A, Sato T, Tsujino I, et al. The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial (18)f-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis. J Nucl Cardiol 2016;23:244-52.CrossRefPubMed

Bois JP, Chareonthaitawee P. Optimizing radionuclide imaging in the assessment of cardiac sarcoidosis. J Nucl Cardiol 2016;23:253-5.CrossRefPubMed

Castano A, DeLuca A, Weinberg R, Pozniakoff T, Blaner WS, Pirmohamed A, et al. Serial scanning with technetium pyrophosphate (99mTc-PYP) in advanced attr cardiac amyloidosis. J Nucl Cardiol 2016;23:1355-63.CrossRefPubMed

10.

Wechalekar AD. Role of imaging in cardiac amyloidosis: An ongoing challenge. J Nucl Cardiol 2016;23:1364-7.CrossRefPubMed

11.

Kero T, Lindsjo L, Sorensen J, Lubberink M. Accurate analysis and visualization of cardiac (11)c-PIB uptake in amyloidosis with semiautomatic software. J Nucl Cardiol 2016;23:741-50.CrossRefPubMed

12.

Dorbala S, Kijewski MF, Park MA. Quantitative molecular imaging of cardiac amyloidosis: The journey has begun. J Nucl Cardiol 2016;23:751-3.CrossRefPubMed

13.

Sadeghi MM. Molecular cardiovascular imaging is ready for prime time: Almost there. J Nucl Cardiol 2016;23:67-70.CrossRefPubMed

14.

Carrio I. Debate: Molecular cardiac imaging is ready for the prime time con between wishful thinking and reality. J Nucl Cardiol 2016;23:64-6.CrossRefPubMed

15.

Strauss HW, Narula J. Pessimistic prophets. J Nucl Cardiol 2016;23:71-2.CrossRefPubMed

16.

Oldan JD, Shah SN, Brunken RC, DiFilippo FP, Obuchowski NA, Bolen MA. Do myocardial PET-MR and PET-CT FDG images provide comparable information? J Nucl Cardiol 2016;23:1102-9.CrossRefPubMed

17.

Seals SR, Aban IB. Analysis of the 17-segment left ventricle model using generalized estimating equations. J Nucl Cardiol 2016;23:1110-1.CrossRefPubMed

18.

Lairez O, Robson PM, Fayad ZA. Time to move to pet-mr for cardiovascular imaging. J Nucl Cardiol 2016;23:1112-3.CrossRefPubMed

19.

Gulati A, Ismail TF, Jabbour A, Alpendurada F, Guha K, Ismail NA, et al. The prevalence and prognostic significance of right ventricular systolic dysfunction in nonischemic dilated cardiomyopathy. Circulation 2013;128:1623-33.CrossRefPubMed

20.

Wang L, Ma X, Xiang L, Lu M, Yan C, Zhao S, et al. The characterization and prognostic significance of right ventricular glucose metabolism in non-ischemic dilated cardiomyopathy. J Nucl Cardiol 2016;23:758-67.CrossRefPubMed

21.

Neglia D. Positron emission tomography: An additional prognostic tool in dilated cardiomyopathy? J Nucl Cardiol 2016;23:768-72.CrossRefPubMed

22.

Yang Y, Yam Y, Chen L, Aljizeeri A, Aliyary Ghraboghly S, Al-Harbi I, et al. Assessment of left ventricular ejection fraction using low radiation dose computed tomography. J Nucl Cardiol 2016;23:414-21.CrossRefPubMed

23.

Phillips LM, Shaw LJ. Approaches to measuring ejection fraction: Many tools, but how to decide which one? J Nucl Cardiol 2016;23:423-4.CrossRefPubMed

24.

Chen L, Wang X, Bao J, Geng C, Xia Y, Wang J. Direct comparison of cardiovascular magnetic resonance and single-photon emission computed tomography for detection of coronary artery disease: A meta-analysis. PLoS ONE 2014;9:e88402.CrossRefPubMedPubMedCentral

25.

Ahmad IG, Abdulla RK, Klem I, Margulis R, Ivanov A, Mohamed A, et al. Comparison of stress cardiovascular magnetic resonance imaging (CMR) with stress nuclear perfusion for the diagnosis of coronary artery disease. J Nucl Cardiol 2016;23:287-97.CrossRefPubMed

26.

Tamaki N. New pet system permits reliable estimates of myocardial blood flow and flow reserve. J Nucl Cardiol 2016;23:473-4.CrossRefPubMed

27.

Suda M, Onoguchi M, Tomiyama T, Ishihara K, Takahashi N, Sakurai M, et al. The reproducibility of time-of-flight pet and conventional pet for the quantification of myocardial blood flow and coronary flow reserve with (13)n-ammonia. J Nucl Cardiol 2016;23:457-72.CrossRefPubMed

28.

Dunet V, Klein R, Allenbach G, Renaud J, deKemp RA, Prior JO. Myocardial blood flow quantification by rb-82 cardiac PET/CT: A detailed reproducibility study between two semi-automatic analysis programs. J Nucl Cardiol 2016;23:499-510.CrossRefPubMed

29.

Morgan CJ, Aban I. Methods for evaluating the agreement between diagnostic tests. J Nucl Cardiol 2016;23:511-3.CrossRefPubMed

30.

Rischpler C, Nekolla SG, Kossmann H, Dirschinger RJ, Schottelius M, Hyafil F, et al. Upregulated myocardial CXCR4-expression after myocardial infarction assessed by simultaneous GA-68 pentixafor PET/MRI. J Nucl Cardiol 2016;23:131-3.CrossRefPubMed

31.

de Haan S, Rijnierse MT, Harms HJ, Verberne HJ, Lammertsma AA, Huisman MC, et al. Myocardial denervation coincides with scar heterogeneity in ischemic cardiomyopathy: A PET and CMR study. J Nucl Cardiol 2016;23:1480-8.CrossRefPubMed

32.

Christian TF. A rose by any other name. J Nucl Cardiol 2016;23:1489-92.CrossRefPubMed

33.

Duvernoy CS, Raffel DM, Swanson SD, Jaiswal M, Mueller G, el Ibrahim S, et al. Left ventricular metabolism, function, and sympathetic innervation in men and women with type 1 diabetes. J Nucl Cardiol 2016;23:960-9.CrossRefPubMed

34.

Mikhalkova D, McGill JB, Peterson LR. ‘SeXX’ matters: In the myocardium of patients with type 1 diabetes. J Nucl Cardiol 2016;23:970-2.CrossRefPubMed

35.

van den Hoogen IJ, de Graaf MA, Roos CJ, Leen AC, Kharagjitsingh AV, Wolterbeek R, et al. Prognostic value of coronary computed tomography angiography in diabetic patients without chest pain syndrome. J Nucl Cardiol 2016;23:24-36.CrossRefPubMed

36.

Berman DS, Budoff MJ, Min JK, Raggi P, Rozanski A, Shaw L, et al. Non-invasive imaging in assessment of the asymptomatic diabetic patient: Is it of value? J Nucl Cardiol 2016;23:37-41.CrossRefPubMed

37.

Qureshi WT, Alirhayim Z, Khalid F, Al-Mallah MH. Prognostic value of extracardiac incidental findings on attenuation correction cardiac computed tomography. J Nucl Cardiol 2016;23:1266-74.CrossRefPubMed

38.

Bhambhvani P. The good, bad, and ugly of incidental findings on cardiovascular-computed tomography. J Nucl Cardiol 2016;23:1275-9.CrossRefPubMed

Title: Review of Cardiovascular Imaging in the Journal of Nuclear Cardiology in 2016. Part 1 of 2: Positron Emission Tomography, Computed Tomography and Magnetic Resonance
Authors: Wael AlJaroudi, MD
Fadi G. Hage, MD
Publication date: 01-04-2017
Publisher: Springer US
Published in: Journal of Nuclear Cardiology / Issue 2/2017
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI: https://doi.org/10.1007/s12350-017-0820-4

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Review of Cardiovascular Imaging in the Journal of Nuclear Cardiology in 2016. Part 1 of 2: Positron Emission Tomography, Computed Tomography and Magnetic Resonance

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2017

Arrhythmogenic ventricular cardiomyopathy and sudden cardiac death: Left or right?

Bone marrow hyperplasia detected by gated blood pool imaging

Ventricular arrhythmias and autonomic nervous system: evolving role of radionuclide imaging

What is this image? 2017: Image 6

CME instructions: Conducting and interpreting high-quality systematic reviews and meta-analyses

Characterization of attenuation and respiratory motion artifacts and their influence on SPECT MP image evaluation using a dynamic phantom assembly with variable cardiac defects

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page